Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer

Endocrine therapy is the mainstay of adjuvant treatment for patients with luminal breast cancer. Despite ongoing advances in endocrine therapy to date, a proportion of patients ultimately develop endocrine resistance, resulting in failure of therapy and poor prognosis. Therefore, as part of the grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfarsi, Lutfi H., El Ansari, Rokaya, Masisi, Brendah K., Parks, Ruth, Mohammed, Omar J, Ellis, Ian O., Rakha, Emad A., Green, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352383/
https://www.ncbi.nlm.nih.gov/pubmed/32545448
http://dx.doi.org/10.3390/cancers12061549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352383/
https://www.ncbi.nlm.nih.gov/pubmed/32545448
http://dx.doi.org/10.3390/cancers12061549

Ejemplares similares